Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation

An increased understanding of infant antibody responses to RSV infection would greatly facilitate vaccine development. Goodwin et  al. isolate and structurally characterize antibodies from RSV-infected infants and identify potent neutralizing antibodies that lack somatic hypermutation. The results provide a framework for the rational design of age-specific RSV vaccines.

Source: Immunity - January 23, 2018 Category: Allergy & Immunology Authors: Eileen Goodwin, Morgan S.A. Gilman, Daniel Wrapp, Man Chen, Joan O. Ngwuta, Syed M. Moin, Patricia Bai, Arvind Sivasubramanian, Ruth I. Connor, Peter F. Wright, Barney S. Graham, Jason S. McLellan, Laura M. Walker Tags: Article Source Type: research